Biodegradable Hemostat Market Report 2025

The biodegradable hemostat market size has grown rapidly in recent years. It will grow from $0.88 billion in 2024 to $0.97 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. The growth during the historical period can be attributed to increased awareness of post-surgical complications, supportive government regulations, a rise in chronic diseases such as cancer and cardiovascular disorders, expansion in the number of hospitals and surgical centers, and heightened investment in healthcare infrastructure.

The biodegradable hemostat market size is expected to see rapid growth in the next few years. It will grow to $1.48 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth anticipated in the forecast period can be attributed to the increasing number of surgical procedures globally, a growing preference for biodegradable medical products, rising cases of trauma and accidents, an aging population, and higher demand for minimally invasive surgeries. Key trends expected during this period include advancements in wound care technology, innovations in biodegradable materials, increased demand for absorbable implants, enhanced product packaging and delivery formats, and the development of hybrid hemostats.

The growing number of surgical procedures is anticipated to drive the expansion of the biodegradable hemostat market. Surgical procedures involve medical operations conducted by healthcare professionals using specialized tools to treat, repair, or remove body parts for health reasons. This increase in surgeries is primarily due to the rising prevalence of chronic diseases, which often require surgical intervention to manage conditions and improve patient outcomes. Biodegradable hemostats provide benefits during surgery by breaking down naturally within the body after use, eliminating the need for removal and reducing the risk of post-operative complications. For example, in March 2023, the British Association of Aesthetic Plastic Surgeons (BAAPS), a UK-based professional body, reported that 31,057 cosmetic procedures were performed in 2022, representing a 102% increase from the previous year. Women accounted for 93% of these procedures, showing a 101% rise compared to 2021. Hence, the rise in surgical procedures is boosting the biodegradable hemostat market.

The increasing frequency of trauma and accidents is expected to further fuel growth in the biodegradable hemostat market. Trauma and accidents are unexpected incidents causing physical injuries due to external forces like falls, impacts, or collisions, often requiring urgent medical care. This rise in trauma cases is largely driven by an increase in road traffic accidents, which result from higher vehicle usage and rapid urbanization, exposing more individuals to hazardous driving conditions. Biodegradable hemostats are in greater demand in such cases as they quickly control severe bleeding and safely degrade within the body, making them especially valuable in emergency and surgical settings. For instance, in May 2024, Transport Canada, a Canadian government agency, reported that motor vehicle fatalities increased to 1,931 in 2022, a 6% rise from 1,821 deaths in 2021. Serious injuries also grew by 8.1%, climbing from 8,185 in 2021 to 8,851 in 2022. Therefore, the rise in trauma and accidents is propelling the biodegradable hemostat market forward.

Key players in the biodegradable hemostat market are concentrating on developing innovative solutions such as plant-based cellulose matrices to rapidly control bleeding and reduce blood loss. Plant-based cellulose matrices are biodegradable materials derived from plant fibers that provide a natural support structure and are safely absorbed by the body, making them suitable for medical use. In April 2024, LifeScience PLUS, a US-based medical device company, introduced DonorSeal, a distinctive hemostatic dressing made entirely from plant-sourced cellulose. DonorSeal forms a gel upon contact with blood, effectively stopping bleeding while being fully biodegradable, absorbable, non-toxic, and pH neutral, making it safe for patients on blood thinners. It also creates a moist, soothing environment that promotes natural tissue healing. The dressing can be removed easily without reopening wounds or sticking, enhancing comfort and speeding recovery at donor sites.

Major players in the biodegradable hemostat market are Johnson & Johnson Services Inc., Medtronic Plc, Medline Industries LP, Becton, Dickinson and Co., Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Samyang Holdings Corp., Mölnlycke Health Care AB, GELITA Medical GmbH, B. Braun Melsungen AG, Tricol Biomedical Inc., Medtrade Products Limited, CryoLife Inc., Hemostasis LLC, Cura Medical, RevMedx Inc., Speed Care Mineral GmbH, Regenity, and C. R. Bard Inc.

North America was the largest region in the biodegradable hemostat market in 2024. The regions covered in biodegradable hemostat report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the biodegradable hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biodegradable hemostat market consists of sales of polysaccharide hemostatic powders, flowable hemostatic agents, plant-based absorbable hemostats, and hydrogel-based hemostatic patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The biodegradable hemostat market research report is one of a series of new reports that provides biodegradable hemostat market statistics, including biodegradable hemostat industry global market size, regional shares, competitors with a biodegradable hemostat market share, detailed biodegradable hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the biodegradable hemostat industry. This biodegradable hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A biodegradable hemostat is a medical device designed to assist in blood clotting and control bleeding by triggering or speeding up the body’s natural coagulation process. It is made to be safely absorbed and broken down by the body over time, eliminating the need for surgical removal. These hemostats are developed with biocompatibility to reduce the risk of adverse reactions while promoting wound healing.

The main types of biodegradable hemostats include natural polymer-based, synthetic polymer-based, composite, cellulose-based, and gelatin-based hemostats. Natural polymer-based hemostats are derived from naturally sourced polymers that aid in stopping bleeding by supporting blood clot formation during medical procedures. They come in various forms such as powders, granules, liquids, foams, and films or sheets, and are used in surgeries, trauma care, dental procedures, laparoscopic surgeries, and more. These products are distributed through direct sales, distributors, e-commerce platforms, pharmaceutical retailers, and healthcare supply companies, serving end users like hospitals, ambulatory surgical centers, clinics, research labs, and others.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.